Joel D A Tyndall

发表

Update 1 of: Beta-strand mimetics.

D. Fairlie, W. A. Loughlin, J. Tyndall, 2010, Chemical reviews.

Conformationally homogeneous cyclic tetrapeptides: useful new three-dimensional scaffolds.

D. Fairlie, J. Tyndall, M. Kelso, 2003, Journal of the American Chemical Society.

A theory of mode of action of azolylalkylquinolines as DNA binding agents using automated flexible ligand docking.

Armin Madadkar Sobhani, Ali Khalaj, E. Azizi, 2006, Journal of molecular graphics & modelling.

Over one hundred peptide-activated G protein-coupled receptors recognize ligands with turn structure.

Bernhard Pfeiffer, D. Fairlie, B. Pfeiffer, 2005, Chemical reviews.

Enzyme adaptation to inhibitor binding: a cryptic binding site in phenylethanolamine N-methyltransferase.

Christine L Gee, Jennifer L. Martin, C. Gee, 2007, Journal of medicinal chemistry.

Comparative Agonist/Antagonist Responses in Mutant Human C5a Receptors Define the Ligand Binding Site*

A. Higginbottom, P. Monk, D. Fairlie, 2005, Journal of Biological Chemistry.

Proteases and protease inhibitors in infectious diseases

A. Gamble, J. Tyndall, W. Huston, 2018, Medicinal research reviews.

Update 1 of: Proteases universally recognize beta strands in their active sites.

D. Fairlie, J. Tyndall, Tessa A Nall, 2010, Chemical reviews.

Proteases universally recognize beta strands in their active sites.

D. Fairlie, J. Tyndall, Tessa A Nall, 2005, Chemical reviews.

Mode of binding of methyl acceptor substrates to the adrenaline-synthesizing enzyme phenylethanolamine N-methyltransferase: implications for catalysis.

Christine L Gee, Qian Wu, Michael J McLeish, 2005, Biochemistry.

Beta-strand mimicking macrocyclic amino acids: templates for protease inhibitors with antiviral activity.

D. Fairlie, R. Reid, J. Tyndall, 2002, Journal of medicinal chemistry.

Site-directed Mutagenesis and Kinetic Studies of the West Nile Virus NS3 Protease Identify Key Enzyme-Substrate Interactions*

Martin J. Stoermer, D. Fairlie, P. Young, 2005, Journal of Biological Chemistry.

GPCR agonists and antagonists in the clinic.

J. Tyndall, Joel D A Tyndall, Radhika Sandilya, 2005, Medicinal chemistry (Shariqah (United Arab Emirates)).

Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.

John C Ashton, J. Tyndall, Joel D A Tyndall, 2008, Current medicinal chemistry.

Countering cooperative effects in protease inhibitors using constrained beta-strand-mimicking templates in focused combinatorial libraries.

Terry Walsh, Jennifer L. Martin, D. Fairlie, 2004, Journal of medicinal chemistry.